Page last updated: 2024-11-05

thiethylperazine and Acute Disease

thiethylperazine has been researched along with Acute Disease in 3 studies

Thiethylperazine: A dopamine antagonist that is particularly useful in treating the nausea and vomiting associated with anesthesia, mildly emetic cancer chemotherapy agents, radiation therapy, and toxins. This piperazine phenothiazine does not prevent vertigo or motion sickness. (From AMA Drug Evaluations Annual, 1994, p457)
thiethylperazine : A member of the class of phenothiazines that is perazine substituted by a ethylsulfanyl group at position 2.

Acute Disease: Disease having a short and relatively severe course.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dahlerup, B1
Hostrup-Pedersen, C1
Engbaek, J1
Richter, HR1
Briellmann, A1

Other Studies

3 other studies available for thiethylperazine and Acute Disease

ArticleYear
[Acute facial dyskinesia after treatment with thiethylperazine (Torecan)].
    Ugeskrift for laeger, 1976, Dec-13, Volume: 138, Issue:51

    Topics: Acute Disease; Administration, Oral; Adolescent; Biperiden; Dyskinesia, Drug-Induced; Face; Female;

1976
[Acute dyskinesia in children treated with thiethylperazine (Torecan)].
    Ugeskrift for laeger, 1975, Mar-24, Volume: 137, Issue:13

    Topics: Acute Disease; Child; Humans; Movement Disorders; Thiethylperazine; Vertigo

1975
[Acute dyskinesia following short-term antiemetic medication].
    Schweizerische medizinische Wochenschrift, 1969, Jul-26, Volume: 99, Issue:31

    Topics: Acute Disease; Adult; Diagnosis, Differential; Female; Humans; Movement Disorders; Prochlorperazine;

1969